盐酸伊立替康三水合物 T0486

Product Introduction
Bioactivity


英文名: Irinotecan hydrochloride trihydrate

描述: Irinotecan hydrochloride trihydrate (CPT-11 HCl Trihydrate) 通过抑制拓扑异构酶 1 来防止 DNA 展开，可研究结肠癌和直肠癌。

细胞实验: Exponentially growing cells (LoVo and HT-29 cells) are seeded in 20 cm2 Petri dishes with an optimal cell number for each cell line (2 × 104 for LoVo cells, 105 for HT-29 cells). They are treated 2 days later with increasing concentrations of Irinotecan or SN-38 for one cell doubling time (24 hours for LoVo cells, 40 hours for HT-29 cells). After washing with 0.15 M NaCl, the cells are further grown for two doubling times in normal medium, detached from the support with trypsin-EDTA and counted in a hemocytometer. The IC50 values are then estimated as the Irinotecan or SN-38 concentrations responsible for 50% growth inhibition as compared with cells incubated without Irinotecan or SN-38. (Only for Reference)

体外活性: 在肝脏,胃,十二指肠和结肠中,单剂量的Irinotecan能够显著增加拓扑异构酶I与DNA的共价结合数量.并且与对照组相比,Irinotecan处理组的结肠黏膜细胞中DNA链断裂数量明显较高.在COLO320异种移植物中,Irinotecan诱导92%的最大生长抑制.

体内活性: 在LoVo细胞和HT-29细胞系中,IC50浓度的Irinotecan诱导相似数量的可裂解复合物。SN-38浓度依赖性的诱导可裂解复合物的形成,这在LoVo细胞和HT-29细胞系中没有明显差异。Irinotecan在细胞中的积聚存在显著差异,在HT-29细胞中的水平始终高于LoVo细胞。 在血浆,肠道和肿瘤组织中,Irinotecan被羧酸酯酶活化为SN-38（主要经肝脏活化）,从而可与其靶点,拓扑异构酶I相互作用。在水溶液中Irinotecan的内酯E环和SN-38水解是可逆的,其羧酸盐和内酯形式的互变取决于温度和PH。在肿瘤和正常组织中,对于同一浓度的SN-38葡糖苷酸和Irinotecan,β-葡糖醛酸酶介导的SN-38产率均高于Irinotecan 形成的SN-38产率。在SCLC细胞系中,Irinotecan的活性明显高于NSCLC细胞系,而在组织学分型中并未观察到SN-38有明显的差异。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: H2O : 1 mg/mL (1.47 mM)
Ethanol : 7 mg/mL (10.33 mM)
DMSO : 45 mg/mL (66.45 mM)


关键字: CPT-11 hydrochloride | inhibit | Irinotecan hydrochloride | Inhibitor | (+)-Irinotecan hydrochloride | Topoisomerase | Irinotecan hydrochloride trihydrate | Irinotecan hydrochloride Trihydrate | Irinotecan HCl | Irinotecan Hydrochloride | Autophagy | CPT-11 HCl

相关产品: Ellipticine | LMP744 hydrochloride | Gimatecan HCl | Rebeccamycin | Tubulin inhibitor 35 | Sparfloxacin | Levofloxacin | Novobiocin Sodium | Topoisomerase I inhibitor 9 | ARN-21934

相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Alkaloid Natural Product Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library | Bioactive Compound Library

盐酸伊立替康三水合物 T0486信息由TargetMol中国为您提供，如您想了解更多关于盐酸伊立替康三水合物 T0486报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途